Corporate giving
Select the MS Trust as your company's charity partner or charity of the year and support the more than 150,000 people in the UK with multiple sclerosis.
With the interests of people with MS at our core, we believe it is important to work cooperatively with all stakeholders in MS, including the pharmaceutical, medical equipment and biotechnology companies and contract research organisations.
Funding from industry supporters goes towards our work with health professionals. We will not accept industry funding for our publications for people affected by MS.
We will always ensure the integrity and independence of the MS Trust is maintained. All industry funding will be acknowledged on our website.
| Name of supporter | Donations made year ending 31 July 2024 | Donations made year ending 31 July 2023 |
|---|---|---|
| Biogen Idec Ltd | £5,950 | £18,640 |
| Clinisupplies | £4,684 | - |
| Coloplast | £14,344 | £5,790 |
| Genzyme, a Sanofi company | £65,000 | £32,000 |
| Hollister | £4,449 | £4,380 |
| Janssen | £40,000 | £32,140 |
| Jazz Pharmaceuticals | £2,999 | - |
| MacGregor | - | £4,950 |
| Medtronic | £2,999 | £2,500 |
| Merck Serono Ltd | £77,776 | £33,463 |
| Novartis Pharmaceuticals UK Ltd | £45,985 | £81,123 |
| Odstock | £3,234 | £2,500 |
| Ottobok | - | £2,640 |
| Qufora | £4,449 | - |
| Roche Products Ltd | £93,703 | £71,127 |
| Rokshaw | £4,449 | £4,350 |
| Sandoz | £40,552 | £32,130 |
| Teva UK Ltd | £4,449 | £4,370 |
| Wellspect | £3,234 | £3,160 |